VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q61195257 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010723.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q61195257‏
024 ‎‡a 0000-0001-7613-795X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q61195257‏
100 0 ‎‡a María R Pazos‏ ‎‡c researcher ORCID ID = 0000-0001-7613-795X‏ ‎‡9 en‏
400 0 ‎‡a María R Pazos‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model‏
670 ‎‡a Author's Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.‏
670 ‎‡a Author's Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs‏
670 ‎‡a Author's Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets.‏
670 ‎‡a Author's Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa‏
670 ‎‡a Author's Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.‏
670 ‎‡a Author's Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.‏
670 ‎‡a Author's Cannabinoids: novel medicines for the treatment of Huntington's disease.‏
670 ‎‡a Author's Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance‏
670 ‎‡a Author's Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].‏
670 ‎‡a Author's Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.‏
670 ‎‡a Author's Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.‏
670 ‎‡a Author's Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets‏
670 ‎‡a Author's Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.‏
670 ‎‡a Author's Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.‏
670 ‎‡a Author's Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.‏
670 ‎‡a Author's Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle.‏
670 ‎‡a Author's Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice.‏
670 ‎‡a Author's Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.‏
670 ‎‡a Author's New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking‏
670 ‎‡a Author's Proliferation of osteoblast precursor cells on the surface of TiO<sub>2</sub> nanowires anodically grown on a β-type biomedical titanium alloy‏
670 ‎‡a Author's Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease‏
670 ‎‡a Author's Role of the endocannabinoid system in Alzheimer's disease: new perspectives.‏
670 ‎‡a Author's Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.‏
670 ‎‡a Author's The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages‏
670 ‎‡a Author's The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.‏
670 ‎‡a Author's The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways‏
670 ‎‡a Author's The endocannabinoid system in Huntington's disease.‏
670 ‎‡a Author's The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.‏
670 ‎‡a Author's Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties‏
909 ‎‡a (orcid) 000000017613795x‏ ‎‡9 1‏
919 ‎‡a roleofinterleukin1betaintheinflammatoryresponseinafattyacidamidehydrolaseknockoutmousemodelofalzheimersdisease‏ ‎‡A Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a colocalizationofcb1receptorswithl1andgap43inforebrainwhitematterregionsduringfetalratbraindevelopmentevidenceforaroleofthesereceptorsinaxonalgrowthandguidance‏ ‎‡A Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance‏ ‎‡9 1‏
919 ‎‡a neuroprotectiveeffectsofcannabidiolinhypoxicischemicinsultthetherapeuticwindowinnewbornmice‏ ‎‡A Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice.‏ ‎‡9 1‏
919 ‎‡a roleoftheendocannabinoidsysteminalzheimersdiseasenewperspectives‏ ‎‡A Role of the endocannabinoid system in Alzheimer's disease: new perspectives.‏ ‎‡9 1‏
919 ‎‡a cannabinoidsnovelmedicinesforthetreatmentofhuntingtonsdisease‏ ‎‡A Cannabinoids: novel medicines for the treatment of Huntington's disease.‏ ‎‡9 1‏
919 ‎‡a newpyridazinone4carboxamidesasnewcannabinoidreceptortype2inverseagonistssynthesispharmacologicaldataandmoleculardocking‏ ‎‡A New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking‏ ‎‡9 1‏
919 ‎‡a cannabinoidcb2receptorsinthemousebrainrelevanceforalzheimersdisease‏ ‎‡A Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.‏ ‎‡9 1‏
919 ‎‡a tricyclicpyrazolespart8synthesisbiologicalevaluationandmodellingoftricyclicpyrazolecarboxamidesaspotentialcb2receptorligandswithantagonistinverseagonistproperties‏ ‎‡A Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties‏ ‎‡9 1‏
919 ‎‡a inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag‏ ‎‡A The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.‏ ‎‡9 1‏
919 ‎‡a corrigendumtobiologicalcharacterizationofpm226achromenoisoxazoleasaselectivecb2receptoragonistwithneuroprotectiveprofile‏ ‎‡A Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].‏ ‎‡9 1‏
919 ‎‡a cannabinoidcb1receptorsareexpressedbyparietalcellsofthehumangastricmucosa‏ ‎‡A Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa‏ ‎‡9 1‏
919 ‎‡a targetingcb2gpr55receptorheteromersmodulatescancercellsignaling‏ ‎‡A Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.‏ ‎‡9 1‏
919 ‎‡a neuronalandnonneuronalbradykininreceptorsareinvolvedinthecontractionandorrelaxationtothepigbladdernecksmoothmuscle‏ ‎‡A Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle.‏ ‎‡9 1‏
919 ‎‡a endocannabinoidsysteminhuntingtonsdisease‏ ‎‡A The endocannabinoid system in Huntington's disease.‏ ‎‡9 1‏
919 ‎‡a activationofcannabinoidcb2receptorsstimulatesinsituandinvitrobetaamyloidremovalbyhumanmacrophages‏ ‎‡A The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages‏ ‎‡9 1‏
919 ‎‡a neuroprotectiveeffectsofphytocannabinoidbasedmedicinesinexperimentalmodelsofhuntingtonsdisease‏ ‎‡A Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.‏ ‎‡9 1‏
919 ‎‡a microglialcb2cannabinoidreceptorsareneuroprotectiveinhuntingtonsdiseaseexcitotoxicity‏ ‎‡A Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.‏ ‎‡9 1‏
919 ‎‡a cannabidiolreduceslunginjuryinducedbyhypoxicischemicbraindamageinnewbornpiglets‏ ‎‡A Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets.‏ ‎‡9 1‏
919 ‎‡a cannabinoidquinolvce0048alleviatesbleomycininducedsclerodermaandexertspotentantifibroticeffectsthroughperoxisomeproliferatoractivatedreceptorγandcb2pathways‏ ‎‡A The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways‏ ‎‡9 1‏
919 ‎‡a lossofstriataltype1cannabinoidreceptorsisakeypathogenicfactorinhuntingtonsdisease‏ ‎‡A Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.‏ ‎‡9 1‏
919 ‎‡a proliferationofosteoblastprecursorcellsonthesurfaceoftiosub2subnanowiresanodicallygrownonaβtypebiomedicaltitaniumalloy‏ ‎‡A Proliferation of osteoblast precursor cells on the surface of TiO<sub>2</sub> nanowires anodically grown on a β-type biomedical titanium alloy‏ ‎‡9 1‏
919 ‎‡a aeegandneurologicexamfindingscorrelatewithhypoxicischemicbraindamageseverityinapigletsurvivalmodel‏ ‎‡A aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model‏ ‎‡9 1‏
919 ‎‡a effectsofcannabidiolandhypothermiaonshorttermbraindamageinnewbornpigletsafteracutehypoxiaischemia‏ ‎‡A Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.‏ ‎‡9 1‏
919 ‎‡a cannabinoidcb2receptoragonistsprotectthestriatumagainstmalonatetoxicityrelevanceforhuntingtonsdisease‏ ‎‡A Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.‏ ‎‡9 1‏
919 ‎‡a biologicalcharacterizationofpm226achromenoisoxazoleasaselectivecb2receptoragonistwithneuroprotectiveprofile‏ ‎‡A Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.‏ ‎‡9 1‏
919 ‎‡a identificationofnovelgpr55modulatorsusingcellimpedancebasedlabelfreetechnology‏ ‎‡A Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.‏ ‎‡9 1‏
919 ‎‡a cannabinoidagonistwin55212reducesbraindamageinaninvivomodelofhypoxicischemicencephalopathyinnewbornrats‏ ‎‡A The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.‏ ‎‡9 1‏
919 ‎‡a hypoxicischemicbraindamageinducesdistantinflammatorylunginjuryinnewbornpiglets‏ ‎‡A Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets‏ ‎‡9 1‏
919 ‎‡a cannabidiolreducesbraindamageandimprovesfunctionalrecoveryafteracutehypoxiaischemiainnewbornpigs‏ ‎‡A Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs‏ ‎‡9 1‏
919 ‎‡a endocannabinoidsregulatetheactivityofastrocytichemichannelsandthemicroglialresponseagainstaninjuryinvivostudies‏ ‎‡A Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000044669778‏
996 ‎‡2 BNE|XX5216957‏
996 ‎‡2 SIMACOB|420497667‏
996 ‎‡2 BNF|16575914‏
996 ‎‡2 BNF|17085387‏
996 ‎‡2 J9U|987007329969305171‏
996 ‎‡2 SUDOC|16682965X‏
996 ‎‡2 LC|no2009073868‏
996 ‎‡2 LC|n 2008019976‏
996 ‎‡2 SUDOC|165529512‏
996 ‎‡2 LC|no2012025801‏
996 ‎‡2 LC|n 2004000707‏
996 ‎‡2 SUDOC|072236272‏
996 ‎‡2 ISNI|0000000365835925‏
996 ‎‡2 BNC|981058602708806706‏
996 ‎‡2 NKC|mub20221138860‏
996 ‎‡2 LC|n 91090254‏
996 ‎‡2 DNB|1056622113‏
996 ‎‡2 ISNI|0000000079776741‏
996 ‎‡2 LC|no2002083045‏
996 ‎‡2 DNB|105643404X‏
996 ‎‡2 BIBSYS|90820462‏
996 ‎‡2 BNC|981058522669306706‏
996 ‎‡2 SUDOC|184324890‏
996 ‎‡2 BNF|13741158‏
996 ‎‡2 ISNI|0000000040202943‏
996 ‎‡2 LC|ns2011001923‏
996 ‎‡2 DNB|1057608815‏
996 ‎‡2 SUDOC|094989877‏
996 ‎‡2 LC|no2010149285‏
996 ‎‡2 DNB|1051294320‏
996 ‎‡2 LC|no 93018095‏
996 ‎‡2 BNE|XX1695776‏
996 ‎‡2 SUDOC|257022325‏
996 ‎‡2 BNE|XX1546190‏
996 ‎‡2 BNE|XX5635787‏
996 ‎‡2 NUKAT|n 2010052654‏
996 ‎‡2 ISNI|0000000076911784‏
996 ‎‡2 BNE|XX999071‏
996 ‎‡2 DNB|141182008‏
996 ‎‡2 CAOONL|ncf10725143‏
996 ‎‡2 ISNI|0000000381957324‏
996 ‎‡2 DNB|1079222820‏
996 ‎‡2 BNC|981058515612306706‏
996 ‎‡2 BNE|XX958616‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏